What's Happening
E-Bulletin

You are here

Issue No 46

The following jobs and event are currently available. Kindly apply/register directly based on the information provided. Thank you.

• Pharmacy Manager or Senior Pharmacist/Pharmacist – St Luke Hospital

In June 2008, the BMJ published a case report of a suspected case of Reye’s syndrome associated with the use of an oral gel containing choline salicylate in a 20 month old child.  Following that, the UK health authority MHRA has recommended that topical oral pain relief products containing salicylate salts should be contraindicated in children and young people under the age of 16 years.

• FDA Update re: interaction of ceftriaxone with calcium-containing products
• Raptiva/Efalizumab suspended by FDA, US MAH Initiated Phased Withdrawal
• Erlotinib (Tarceva®) Associated with gastrointestinal perforation, SJS and corneal perforation or ulceration

Here are 2 brief news for your quick update:

• GSK sets to buy Stiefel Labs
• US FDA to allow 'morning-after' pill for Young Women

To further bolster the ongoing trials in Thailand and Philippines, the vaccines division of Sanofi-Aventis Group (Sanofi Pasteur) has initiated clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam.

Kindly note that PSS may postpone or cancel upcoming CPE programmes and other gatherings pending the situation of the swin flu situation.
Kindly monitor the individual event and contact the Secretariat or check PSS website if necessary.

On April 9, South Korean health authorities decided to recall and ban the sale of about 1,200 drug products due to contamination with asbestos in one of their excipients - talc. About 120 pharmaceutical manufacturers were affected.